Introduction to Epidemiology


  

 Epidemiology 
Epidemic ! 
   Epi "#!! Upon &
Demos "#!! Population
Logy +, Logos ! Study
0&12 !! 342150&16 7!87 40!0&1298
,1: ;1;!4+#,&;<=0>?,!842150&1 (Epidemic) 4>C8D89E 42#:F8:7!<:
Hippocrates (460 >L ,8 ..) "#!N1F=!,O2&421598=P0Q,! D, 87 <=0
D8# &QF,R=<=0<85<=0:51 Graunt (.. 1662) 1=,!=D4+,
V,!W># X4>C85 Scurvy 0!,,04=4>C8004=88Z 51 Lind (.. 1747) 1=,!
9VF"8>?,!85\L151 Jenner (.. 1796) <=0#,8&N1F 4>C8:F8<&&Q,!!
0&12 N1F< 0&1Q,!,2:598;! London >04,!W 51 Snow (..
1854) =!878!0&12,+#8Z 4V8 <=0>?,!85 Pellagra 51
Goldberger (.. 1923) 8!1=,!"8>?,!85 Poliomyelitis 51 Francis (.. 1954)
D;>N1F !0&1298D:F8Z 4>C84#&50&1<=05:21:,
(Communicable disease) 4+,&7!1 <:98:#f8 5#4>C8>gEQ,!>0V42#4>=#8
R><&&N>4>C85NF4V+7, (Non-communicable disease) <=054+7,! (Chronic disease) 4>C8D89E
4>=#8<>=!1!= 4 3Epidemiologic transition6 <:7!87 NN1F2O #49VF98
50&1<&&412 0ND89VF98>gEQ,!59Z N1F 80&12N1F
k8R><&&Q,!!0&12 4+#,9FN1FQF,R=988N>&;<=0>?,!85NF4V+7, <=0
54+7,!8421R><&&<=02O 9Z Q78=<&&
1!878 2V0&12!NN1F1Q,&4Q:Q,!,R< :4l0 350&16 ,:,N> <:
N1FQQ,&4Q:,,N>5,+#8Z :=,18>gEDOPD;Q#N9V 356 4V8 &14m&<=0
,;&:2 +,<F<:>gE#,R8 ,!<<=0DOPD;Q mD82O<=00&8
!0&12N>9VF98<FNQ>gEN1F 82V=8!4m8F,!8 30&126
N9V 3DQ2V6 (Discipline) 51:! <:4>C8 34+#,!+,6 (Tools) #9VF98>gEDOPD;Q
4m887804>C82! 400&12N48+7,4l04+#,!#4>C8Q,!DQ2V4,! 98QP0#
DQ2V,+#8Z 48+7,2V4l0DQ 4V8 DQ2V5V8D: 984+#,!Q,!,<=0&25
DQ2VW:2D:W:2Q,!8;98<!;:!Z +,DQ2V=D: 5
<=02O!<#4#QF,!&f:1 1!878 0&12 !4>C84+#,9F&!
2O (Methodology) 985<=0>gE!<<=0DOPD;Q <=01F4:;f=874,!
#82V;89Z ,!0&1298q80Q,! 32O6 #9VF982 (Research methodology) "#!
4>C8D2#!#82V;DQ2V4>C8:F,!48RF
2 Medical Epidemiology

% (Definition)
0&124>C8D:#+,=!0Q,!598>0V <=0>g#,2O2=
+,4>C8D4:;#9F4210<&&878 0&12q82!#& 5 +,
4m&>X NN1F421&8;Z 81F5,D#4Z 8 <:8&!80=P0&!,!#4D#!:,
42158,+#8Z =P01!=87 ,4>C8=P0!8O; +,4>C8f=DfD:,
>g&!,!98D2#!<1=F,
1Q,! Epidemiology #82V51#N>,&8#D;1 +,
Epidemiology: 3The study of the distribution and determinants of health-related states or
events in specified populations and the application of this study to control of health problems6 (Last,
1995)
"#!04m8N1F 187N1F84,7!48+7,Q,!DQ2V (Discipline) <=08N>9VF
(Implication) =NF7! 2 >0



 
+,+-.+/

0&12 =P04+,8&V821,+#8Z #984+#,!5 "#!,<&!N1F
4>C8 4 01& N1F<
1. Sub-molecular +, Molecular level "#!N1F< ! Cell biology, Biochemistry <=0
Immunology
2. Tissue +, Organ level "#!N1F< ! Histopathology <=0 Anatomic pathology
3. Individual level "#!N1F< ! Clinical medicine
4. Population level "#!N1F< ! Epidemiology
54+#,9FN1F,!RF#D&RPD# ;1 !4>C8:F,!9VFO2 8;Z 01&

Classification
fRF<80&12,,4>C8 3Classical6 <=0 3Clinical epidemiology6 1!87
Classical (Traditional) epidemiology +, The big E Epidemiology =P04>C8
Population oriented <=04>C8>gEQ,!598V;V8 4V8 >gE#4#QF,!& Nutrition
D2#!<1=F, W:2 Psychosocial D89E Classical epidemiology 0;!48F898F8 Risk factor
#08N>DR>?,!85
Classical epidemiology 878 !<F09VF methodology Q,!<&&418m: <:
4>C898 Health care setting 51:;>0D!=4+#, Improve f=5 7!98<!
Diagnosis, Treatment <=0 Prognosis <=051#;1;!=Q,! Clinical epidemiology +,
4+#,k8:1D28998fRF>X (Clinical decision) 82V<&!8!4 Clinical
epidemiology  3Clinical decision analysis6 <:8751#N><=F 0<&98P<
4+#,4>C8=1D&D8984+#,!Q,! Terminology 0! Classical epidemiology <=0 Clinical
epidemiology !80&12&!=; &EE:2 3Public health epidemiology6 Q784+#,<
9F4m8<::!981F8Q,! Content <=0 Methodology 0!0&127!D,!<Q8!87
8,878 !<DQ,Q,!0&12,,N>:=;>gE<=05# 4V8
Cancer epidemiology +, :>g4D#!# 4V8 Nutritional epidemiology 4>C8:F8 <:
1!=m!!1<821 <=0=Q,!0&1217!412,R
Chapter 1 Introduction to Epidemiology 3

7 78
,9 ,+/: +-.+/

 

0&124>C8D:#D 0<=0=P0418 3 >0 +,
1. 4>C8,!RF#9VF!2D: (Scientific method)
2. 4>C8,!RF#!4215<=02OD+&D84+#,D4:;Q,!5 "#!9F8
0&12=84!0&124>C8 3D:<!42156 (Occurrence
research)
3. 4>C8,!RF#:F,!9VF&D:1F 8,+#8Z #:;>0D!8 98D!4D2D;Q
<=0>?,!85 (Public health promotion and protection)



 
;<
-7;=+>
= +7?:7@
0&12&&:,2D:<<=0DOPD;Q=,! 4V8
1. +C%DEC++, Natural History I Clinical Picture 

!0&12 0V9F<4QF9=P0Q,!59800:!Z N1FV1481Q78
4V8 4+#,! AIDS <=0,Q,!fRF>X 9800:!Z =!# HIV infection 
fRF>X4&8:7!<:42#4>C8 80#!42154DF84=+,1<=0N::=! +,=P0
,<=0,<D1!Q,!Q1 Vitamin A 9800:!Z
2. +77%?+;;< (Mode of Transmission) 
M<N
QF,R=#N1F4m&&98=P0Q,!4\?0!5 (Surveillance) <=0
D,&D85 (Investigation) 09F80&12N1FD;:2q8984+#,!:21:,Q,!5 "#!08N>DR
2DR898Q78:,N> RF984+#,!:21:,87 9F80&12D812O>?,!85N1F
,8#&D4:;#<F2!Q,!5 4V8 !8fR>F X5 AIDS 4+#,>L .. 1981 9F421
D;:2q85 AIDS :21:,!4D8O 9VF4Qml18 <=0N1F&4=+,1+,D#
D14=+,1 9F:<=085&98&;>?,!85 ,24V8 9VF Condom N9VF
4Qml18 <=0 Screen 4=+,1,89FfRF>X  4>C8:F8
3. +
E%7C;@IPQRR,C7  

!82!0&12D89E04>C84+#,9F&D4:; (Cause) +,>g
4D#! (Risk factor) :,4215 4+#,>05V8981F8DOPD;Q D4:;+,>g1!= ,N1F
==P0<=0R><&& "#!9F4210&12<Q8!:!Z : 4V8
Environmental epidemiology >g!1F8D2#!<1=F,
Occupational epidemiology >g!1F8,V
Nutritional epidemiology >g!1F85V8D:
Genetic epidemiology >g!1F88O;
Social epidemiology >g!1F8D! 2:9 <=0
Health service epidemiology >g!1F8&2D;Q
4. +PT+,%

0&12 N1FV+#,4>C8 3D:<!>?,!856 (The science of prevention)
!<F2!0&124!,!410ND2DR8D4:;Q,!5N1F <:QF,R=#N1F
!0&12887 9F=q84!,#08N>9VF98>?,!85N1F4>C8,!1 51N
4>C8:F,!RF984+#,!5,8 4V8
4 Medical Epidemiology

#&E2!18 4>C85#4 Cowpox <=0D!4: 4+#,0&1

Q,!5\L1 (Smallpox) 421Q78 E2!4=870>=,15 9F Edward Jenner 4V+#,4>C8
Cowpox 0D>?,!85\L1N1F !N1F1=,!8D04m1<f= Cowpox 4>C8 Vaccine 9F&
41m >} 6 D>1:, 41m#N1F& Vaccine 878 N1FDfD&5\L1 <:N4215Q78 2O87 !4>C8
#,&<=0>&>;!9VF8:,Z  80#!51N>98#D;1 :,!87<D1!9F4m8 7!Z #RF
4+#,! Virology +, Biology Q,!5!N4>C8#&8198D878 <:D!4:4!,!41D
9F421<82198>?,!85#>0D2O2N1F

;
 1 88>0V 88fRF: <=0,::,2:5 (:, 1,000) 98:&=#
0&1Q,!5 ;! London >04,!W 0!8# 9 ~ ! 2 D2!
.. 1854 <8:&87>0>

/,
%U8P P P V+ R8%%; ,;;
Southwark and Vauxhall Company 167,654 844 5.0
Lambeth Company 19,133 18 0.9

,:,!8#!Q,!>05V8#N1FD!4: N1F< Q,! John Snow 98>L .. 1854

!421,2:5Q7898 London >04,!W 51N1F&QF,R=9VF87 >0>Q,!>0VV898
:&=#0&1Q,!598;! London <=088:51!:!# 1 "#!&,::
598=;fRFN1F& 87>0>&2 Southwark and Vauxhall DR!&2 Lambeth 7! 2 &2878
87<87 Thames 9VF4+,88 <:&2 Lambeth 9VF87#,R:F8<87 ("#!D>8F,)
Snow !D;> D4:;0&1Q,!5987!878 4219VF87D# > <=04>C8QF,R=9F&2
Southwark and Vauxhall 4>=#8N>9VF87:# F8<87 9F>gE0&1Q,!5=1=! :,!87
4V8418 04m8QF,D;>Q,!N1FD!4:4!,!41 51>RF984+#,!
Biology Q,!5
5. +;,7%MRM%CI
C+ E+,7@ X>%,
>g;&887 RF4+#,!5NQF4m&<=0>?,!85# Z N> NN1F4>C84+#,!==&D&8
#NN1F,R98!<<=0DOPD;Q,:,N> >0VV851#N> RF01&8!# #08RF
878 N>>}2&:24>C82:>08981R<=D;QQ,!:84,! <=00:+,+,F8# 0&
>}2&:2:8,!N!0D;Q1 4V8 :F,!&1+# <NFD4,801<O1
+,N 1+#N88=0D,!<F0V=14D#!:,42159+,N +, &>08f
f=NF&,Z 09FN1F&D2:F!#4>C8,8::,D;Q+,N 4>C8:F8 !0&1
2 09FQF,R=D# 8N>9VF98:1D2894+#,!:!Z 4=87N1F4>C8,!1
6. +-.+/ C ; PQ9M%P V+
98!<f89F&2!<<=0DOPD;Q (Health service) fRF#& f21V,&
4>C8:F,!&Q81 Q,&4Q: <=0<858FQ,!>gE 4+,# 0N1F4:&;=<=0D8#9FF,#0
9F&21!= 4V8 1:7!D8&= :7!!&>0P &;&;=!<
!0&120V9FfRF&2&Q81 Q,&4Q: <=02!Q,!>gE1!=N1F4>C8
,!1
Chapter 1 Introduction to Epidemiology 5

7. +[%% %E%7?:7@
988185&!DOPD;Q q+,8!8 4>C8:F,!4>C8Q,!
>gEDOPD;Q878 51=04,1 :1!=,>0,&1F 81=1&DEQ,!
>gE 81<8!&;5 4=+, Community health intervention programme 1
<=0>0428f= <=0>&>;!0&81!=9F>0D2O212#!Q78 :=,181f=0&
(Impact) #4219VF:878Z 4>C8:F8 "#!::!Z 4=87 :!m:F,!,2O
!0&121F87!878
8. +;,7%

M%-
98?,!F,!:,= 4+,# 44D98P#4F;Q4>C85#1,0D4:;
!8 (Occupational disease) +,N1F&D2, +,D2#!DOPR>5,+#8Z
fRF4D0:F,!=q84!,#09F=4V+,#  5#4>C8,R878 421DfD&>g#
4#QF,!&!8+,,#N1F& QF,R=!0&120D9F :,&N1F9801&8#! "#!
D8N>9VF,F!,2!98=N1F 98!:;=:!>04 fRF2<=0P0=RQ;8 0N1F&
,&9F&!=!0&12<=08f=#N1FN>9VF,F !,2!98V78=

The Epidemiological Approach

4215988;878 N4+,88988<:=08 =+, 8&!=;,04D# !98
4215,=;8!# "#!=P0&!,!N4+,88 4V8 ,; ,V q80!D! +,
4q2
5NQF4m&:!Z 988; D4:;<=0>g#>?,!8N1F4>C8D89E >g4=8D7 
F8N1F512O240<=0D,&D8,!4>C80&& =P04l0=;Q,!>0V 4=#421
5 <=0D8Z# 4215878
2O!0&12984+#,<8!>?,!85 >0,&1FQ78:,8:!Z
:,N>87
1.  
CV>:% (Descriptive Epidemiology)
N1F<Q78:,898V821 Descriptive study 4+#,,O2&=P0Q,!421598<!
Q,! &;= 4= <=0D8# "!# 1!=09FfRF,,!4m8D;:2q8Q,!5N1F
2.  
CVC
 = (Analytic Epidemiology)
N1F<Q78:,8984+#,2DR8D;:2q8#N1F:7!NF >g#104>C8D4:;Q,!
5878 D8O&4215+,N ,!N "#! Identify D4:;Q,!5:F,!9VFQ78:,81!87
1. 4+#,9F&D2#!#214>C8D4:;Q,!5878 D8O&4215
+,N
2. D8O# &8784>C8D8O4V2!4:;<=0f=+,N (5>11R98&# 11)
N&D8O +,2DR8N1F D8O#&878 N9VD8O984V2!4:;
<=0f= fRF0:F,!F,8=&N>42#:F8Q78:,8# 1 4+#,D;:+q89
3.  
CVP_,;+ (Operational Epidemiology)
N1F<Q78:,8984+#,1=,!>}2&:21R >g#N1F2DR 8<=F4>C8D4:;Q,!5878
F=1>g+,>?,!8N9FN1F&>g887 <=F 42150=1=!+,N ,!N
6 Medical Epidemiology

F& !<F0<FNQ>g#104>C8D4:;<=Fm: 5m!N=1=! fRF

0:F,!F,8=&N>42#:F8Q78:,8# 1 +, 2 9  D4:;Q,!5#<F2!804>C8,0N <=F
0#!&>g<=02O#9F5=1=!N1F98#D;1
:,!4V8 984+#,! Fluoride 98871+#&4215g8f; 42#:F8#
Descriptive study D!4:& 98+87 ##01& Fluoride 98871+#DR! 0&V;Q,!5g8f;
8F,98+78##01& Fluoride :# QF,R=87&!V7 01& Fluoride 988780>?,!85g8f;N1F !N1F
984V2!24042#4:28& Fluoride 98871+# 80D8O984V2!4:;f=&421
5g8f;2! 878!984V2!1=,!4+#,>?,!8<=0=1>gE5g8f; 519VFV;V8 2 <!#
=P04+,8Z 8 +, Kingston <=0 Newburg 98q New York (Dean HT. Pub Health Rep 1942)
V;V87! 2 <!87 Prevalence Q,!5g8f;4+#,42#:F84+,8Z 8 =!878N1F4:2 Fluoride =!
9887>0>Q,!V;V8 Newburg 4>C84= 10 >L :21:,8 & V;Q,!5g8f;98V;V8 Newburg
=1=!,!8DE 98QP0#V;V8 Kingston N=1=!4= 8,878 !&, V;V8 Antigo 98q
Wisconsin #44:2 Fluoride 9887 N1F0!&:87 98>L 1960 =!878 6 >L & V;Q,!
5g8f;#=1=!<=F =&42#Q78,!4m8N1FV1 =q8<=0D!4:1!= 4>C84+,# !
+88 Fluoride 9887 D>?,!84215g8f;N1F <=0N1F9VF4>C8:98>?,!8g8f;
8>g;&8
82O!0&12N>9VF87 ,N4>C8:F,!f8Q&88&;Q78:,8 &!
P#QF,R=V148+,418V1 fRF ,QF&!Q78:,8N>N1F

+P @+;=MVE 

M%+PT+,%

4>?>0D!#DE,!8#!Q,!0&12N1F< 4D0=;>0V#4D#!:,421
5 7!874+#,F8>g+,=P0&!,!#9F>0V=;8784D#!:,42154+,# 0N1F
<FNQ+,>?,!8 4V8  Screening 4+#,F85:!Z #!N>},98=;>0V#
>g4D#!:,4215
>?,!85,N1F 2 =P0+,
1. Population-Based Approach
N1F<>?,!8#,&=;>0V7!1 4V8 9F<80898&>08,
# Cholesterol :# +,P!4+#,NDR&&;# 4+#,>?,!859Q14=+,1
2. High-Risk Approach
N1F<>?,!84# l0=;4# D#!:,4215 4V8 :4=+,14+#,01&
Cholesterol DR!9841m#>0:21!=98,&
>?,!8<&& Population-based approach D89E04>C8>?,!8#N:F,!9VFDR!
=P0 Non-invasive <=04>C8 Public health approach 4+#,4>&4&&<&& High-risk approach "!#
9VFDR! =P04>C8 Invasive <=04>C8 Clinical approach
98>?,!859FN1Ff=1#D1; fRF8F#4#QF,!0:F,!9VF= P0fDfD88N>7! 2 R><&&



 
 Clinical Practice
0&12NN1FDE:,!8DOPD;Q4878 <:!DE981F8<,
1F 7!8748+#,!<:F,!,QF,R=Q,!>0V (Population-based) 984+#,!:!Z #4#QF,!
&fR>F X DE874,! #9F421D:!0&12<Q8!94+#,8N>9VF!
<514l0 8#8+, Clinical epidemiology 1!87
Chapter 1 Introduction to Epidemiology 7

1. +C
 =
(Diagnosis)

2405, (Symptom) <=0,<D1! (Sign) N1FQF,R=
Q,!=;fRF>X98=P0Q,!!0&12 4V8 #<D282l5=287 9#V821
Mitral regurgitation N1F :& Apical systolic murmur N1F&QF,R= Autopsy
fRF:#& Mitral regurgitation <=F>0:2:&Q,!fRF#:5878 4+#,7!#!V2:,R
2. +7C;@ 
(Etiognosis)
=;,+,=;541898fRF>X#=P0:!8 ,421D4:;#<::!8
:1D28D4:;Q,!598<:=0P804>C8,0N Q78&QF,R=#N1F98=P0Q,!!
0&12 4V8 D4:;,4m&,98fRF>X41m#&0421 Virus +, Group
A Streptococcus +, Mycoplasma 1F QF,R=4=87=F 8<:N1F!0&127!D278
3. +>+:=
(Prognosis)
f=Q,!5<=0504>C8,!N <:F,!,QF,R=#N1F=;fRF>X#
=P04V8418878&QF,R=#,R98,1: 4V8 P004=Q,!598fRF>X #
4>C804m!>,1 +,5,D#5"#!<=F0=&4>C89 4+#,9FN1FQF,R=4=87 4>C8:F,!9VF
2O!0&124V8418
4. +-.+/[ +,+/ (Treatment)
4+#,9F&V821910N1Ff=1#D;1 <:F,!,QF,R=#N1F
fRF>X=;9E#N1F& <:=02O 4V8 4+#,9F&0!fRF>X 
504m!4:F81F Simple mastectomy & Radical mastectomy ,!91N1Ff=18 4>C8
!0&1298R><&&Q,! Clinical trial
5. +C
 =C>I;,7%MRCI++,+/ (Clinical Decision Analysis)
<F0&,!91N1Ff=18984V2!W~ <:8N>9VF!=282
(Clinical practice) 98D4>C82! <4>C8:F,!8!!fRF>X<:=0 "#!=P0,+#8Z #
<::!8 4V8 98P#fRF>X  Hip fracture <0N:1D289 Hip replacement 98fRF>X;N>
<:0:F,!2P,!>0,&:!Z Q,!fRF>X 4V8 ,; 5<"F,8 4D#!:,1D=& <=0
,+#8Z 4+#,:1D289fRF>X <:=0 N1F&f:1+,N 51240f=1f=4D#0421&fRF>X
f:1 F240N1Ff=f:180421f=4D <m0Nf:1fRF>X 
878 QF,R=#8 >0,&:1D2891!= mN1F!0&124V8418

:%@+
1. Beaglehole R. Basic Epidemiology. Geneva: World Health Organization, 1993: 1-11.
2. Friedman GD. Primer of Epidemiology. 4th edition. New York: McGraw-Hill Incorporated, 1994:
1-8.
3. Gordis L. Epidemiology. Philadelphia: WB Saunders Company, 1996: 3-12.
4. Greenberg RS. Medical Epidemiology. 2nd edition. New Jersey: prentice Hall International, 1996:
1-13.
5. Hennekens CH. Epidemiology in Medicine. Boston: Little Brown and Company, 1987: 3-15.
6. Jekel JF. Epidemiology, Biostatistics and Preventive Medicine. Philadelphia: WB Saunders
Company, 1996: 4-16.
7. Kramer MS. Clinical Epidemiology and Biostatistics, A Primer for Clinical Investigators and
Decision-Makers. Berlin: Springer-Verlag, 1988: 3-10.
8 Medical Epidemiology

8. Last JM. A Dictionary of Epidemiology. 3rd edition. New York: Oxford University Press, 1995: 55.
9. Lilienfeld DE. Foundation of Epidemiology. 3rd edition. New York: Oxford University Press, 1994:
1-21.
10. Page RM. Basic Epidemiological Methods and Biostatistics, A Practical Guidebook. Boston: Jones
and Bartlett Publishers, 1995: 1-47.
11. Stone DB. Introduction to Epidemiology. Madison: Brown & Benchmark Publishers, 1996: 1-10.
12. Streiner DL. PDQ Epidemiology. 2nd edition. St. Louise: Mosby, 1996: 1-13.